Dr. Phillips is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MUSC Health Heart & Vascular Columbia Medical Park DT III
1655 Bernardin Ave, Unit 220
Columbia, SC 29204Phone+1 803-409-7170Fax+1 803-409-7175
Summary
- I received my medical degree from the University of South Carolina School of Medicine here in Columbia, SC, after receiving a Bachelor of Science in Biology from The Citadel in Charleston. I completed a residency and internship in internal medicine at University of Virginia Health Sciences Center, where I completed fellowships in both cardiology (as the Chief Cardiology Fellow) and interventional cardiology. I am board certified in interventional cardiology, cardiovascular disease, and internal medicine. I focus on prevention as well as coronary intervention and valvular heart disease including transcatheter aortic valve replacement(TAVR). I currently serve as the President of the Providence heart and vascular institute.
Education & Training
- University of Virginia Medical CenterFellowship, Interventional Cardiology, 2002 - 2003
- University of Virginia Medical CenterFellowship, Cardiovascular Disease, 1998 - 2002
- University of Virginia Medical CenterResidency, Internal Medicine, 1995 - 1998
- University of South Carolina School of MedicineClass of 1995
- CitadelBS, Biology, Cum laude, 1987 - 1991
Certifications & Licensure
- SC State Medical License 2003 - 2025
- VA State Medical License 1997 - 2004
- American Board of Internal Medicine Interventional Cardiology
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Start of enrollment: 2006 Dec 31
- TAXUS Libertē Post Approval Study Start of enrollment: 2009 Dec 01
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) Start of enrollment: 2004 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 285 citationsGenetic inheritance of gene expression in human cell lines.Stephanie A. Monks, Amy Leonardson, H. Zhu, P. Cundiff, P. Pietrusiak
American Journal of Human Genetics. 2004-12-01 - 39 citationsα4β1 Integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) miceKurt G. Barringhaus, J. William Phillips, Jayant Thatte, John M. Sanders, Ann C. Czarnik
Journal of Vascular Research. 2004-07-01 - 66 citationsRosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 DiabetesJ.William Phillips, Kurt G. Barringhaus, John M. Sanders, Zandong Yang, Meng Chen
Circulation. 2003-10-21
Professional Memberships
- Fellow
- Society of Cardiovascular Angiography and InterventionsFellow
External Links
- Profilehttps://providers.muschealth.org/sc/columbia/james-william-phillips-iii-md
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: